Amyloid Bri (1-23) and Amyloid Bri (1-34) peptides are post-translational products of mutated BRI2 gene. Amyloid Bri peptides are found as plaques in brains of patients with Familiar British Dementia (FBD) that shares many common features with Alzheimer’s Disease.
CAT# | A13226 |
CAS | 717122-86-6 |
Synonyms/Alias | Amyloid Bri Protein (1-23) |
M.F/Formula | C116H175N31O35S2 |
M.W/Mr. | 2627.99 |
Sequence | One Letter Code: EASNCFAIRHFENKFAVETLICS-OH Three-Letter Code: H-Glu-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-OH (Disulfide bond) |
Appearance | White powder |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Purotoxin 1, a component from the venom of Geolycosa spiders, exerts selective inhibitory action on P2X3 recep ...
The peptide Difopein, designed, isolated and identified by Haian Fu, is a high affinity inhibitor of 14-3-3 pro ...
Trifluoroacetyl tripeptide-2 (TFA-T2) is an innovative peptide compound that has garnered significant attention in dermatolog ...
Linaclotide, sold under the brand name Linzess, is a synthetic tetradecapeptide and guanylate cyclase (GC-C) rec ...
of skin aging Skin aging is an obvious external manifestation of the natural process occurring in tissues and or ...